Insulet Corporation

Insulet Corporation

PODD·NASDAQ

$146.41

+2.2%
HealthcareMedical - Devices

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

At a Glance

Live Snapshot
Market Cap$10.14B
EPS3.5100
P/E Ratio41.71
Earnings Date08/06/2026

podd

Effect of Foreign Exchange Changes on Cash

Last Annual Value

11.50M

3-Year CAGR

67%

5-Year CAGR

19%

10-Year CAGR

46%

Insulet Corporation

Insulet Corporation Competitors Analysis of Effect of Foreign Exchange Changes on Cash

PODD · NASDAQ
CompanyEffect of Foreign Exchange Changes on Cash
CAGR 3Y
CAGR 5Y
CAGR 10Y
11.50M
85.6%N/A79.0% 
19.10M
176.9%N/AN/A
STE logo
STERIS plc
NYSE:STE
7.20M
N/A-18.4%N/A
BIIB logo
Biogen Inc.
NASDAQ:BIIB
101.90M
42.7%N/AN/A
22.90M
26.2%N/AN/A
24.10M
34.5%N/AN/A
4.00M
N/AN/AN/A
-621.00K
N/AN/AN/A
DXCM logo
DexCom, Inc.
NASDAQ:DXCM
21.50M
142.9%N/AN/A
Insulet Corporation

Insulet Corporation Fair Value Envelope

PODD · NASDAQ

Our analysis suggests that PODD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $146.41, this represents a potential HIDDEN relative to our calculated worth for Insulet Corporation.

Intrinsic Value
Current Price: $146.41